Cannabis Report
Home > Boards > Free Zone > All Trading - Technical > $Most Followed Members$

$DFFN Breaking News DFFN

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
$Pistol Pete$ Member Profile
Member Level 
Followed By 2,164
Posts 227,236
Boards Moderated 74
Alias Born 05/06/14
160x600 placeholder
$Pistol Pete$ Member Level  Thursday, 03/08/18 01:14:07 AM
Re: $Pistol Pete$ post# 18121
Post # of 19389 
$DFFN Breaking News DFFN



“We are pleased to be dosing patients so soon following the opening of the INTACT trial just a few weeks ago,” said David Kalergis, Chief Executive Officer of Diffusion Pharmaceuticals. “We believe that this Phase 3 study will offer new hope for inoperable GBM patients who are administered TSC along with their standard therapies.”

http://investors.diffusionpharma.com/file/Index?KeyFile=391934667



investorshub.advfn.com/$Pistol-Pete$-$Mick$-&-Friends-Stock-Picks-29568/

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist